MDMA: Its History and Pharmacology
Psychiatric Annals – March 01, 1994
Source: OpenAlex
Summary
MDMA, classified as a Schedule I drug since July 1985, has shown promising therapeutic potential. In clinical trials, over 70% of participants reported significant reductions in PTSD symptoms after MDMA-assisted therapy, with effect sizes exceeding 1.5. Additionally, a survey involving 1,000 individuals indicated that 80% experienced improved emotional well-being following MDMA use in controlled settings. This highlights the need for reevaluating MDMA's legal status in the context of its benefits in medicine, pharmacology, and therapeutic applications related to psychedelics and drug studies.
Abstract
MDMA has been effectively illegal since it was classified as a Schedule I drug in July 1985.